Hims & Hers is being sued by the FTC for allegedly violating consumer privacy and potentially charging customers without their knowledge.

A major percentage of US adults are not sure which vaccines the CDC recommends or considers safe during pregnancy.

A fecal microbiota transplantation-based treatment protocol may improve sleep continuity among adults with chronic insomnia.

Glucagon-like peptide-1 receptor agonists are associated with increased gastrointestinal adverse events and no symptom relief ...

Updated 2025-2026 formulations of mRNA-1283 and BNT162b2 protect older adults against severe COVID-19 outcomes and medically attended illness.

Perampanel offers meaningful seizure control and an acceptable safety profile for patients with brain tumor-related epilepsy, a new review shows.

The global morbidity gap, meaning those living in poor health, has been increasing since 1990 and may continue based on trends through 2023.

The FDA has approved Simtriyo (centanafadine), a first-in-class NDSRI and CNS stimulant, for adult and pediatric ADHD aged 6 years and older.

The association between elevated interferon α and Sjögren disease sheds new light on immune pathways and disease.

Expanded genetic testing for amyotrophic lateral sclerosis may increase the demand for longitudinal surveillance of asymptomatic gene carriers.

An outside advisory panel to the FDA is pushing for the production and sale of a few previously banned peptide treatments.

Fecal microbiota transplantation may offer short-term improvements in motor function and constipation severity for adults with Parkinson disease.